ContextVision

ContextVision Stock-Based Compensation

Stock-Based Compensation (SBC) of ContextVision (CONTX.OL) as of Nov 19, 2026.

Stock-Based Compensation

-SEK

Last updated:

Stock-Based Compensation (SBC) of ContextVision is 2026 - SEK. Stock-Based Compensation (SBC) of ContextVision was 2025 - SEK. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ContextVision Stock analysis

What does ContextVision do? ContextVision AB is a global provider of medical imaging software, specializing in the development and provision of advanced software for use in radiology, mammography, ultrasound, and digital pathology. They offer a wide range of products, including VOCAL for three-dimensional analysis of volume data, GOPView® US for real-time optimization of ultrasound images, and INIFY Prostate for the analysis of tissue samples in prostate cancer. The company is committed to continuous improvement and innovation, working closely with customers and partners to exchange ideas and incorporate innovative technologies in modern medicine. ContextVision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContextVision stock

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) ContextVision since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s ContextVision historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ContextVision

All Key Metrics — ContextVision